Sleep-disordered breathing and reductions in renal function: Are they associated in the elderly?

Sleep Medicine

Volumn 9, Issue 6, 2008, Pages 598-600

  Markou, Nikolaos ^a   Kanakaki, Maria ^a  

^a NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDITORIAL; ELDERLY CARE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MICROALBUMINURIA; OBESITY; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; SLEEP DISORDERED BREATHING;

AGED; GLOMERULAR FILTRATION RATE; HUMANS; RENAL INSUFFICIENCY; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 48449086510     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2007.10.013     Document Type: Editorial

References (24)

1. Chakravorty I., Shastry M., and Farrington K. Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment. Nephrol Dial Transplant 22 (2007) 28-31
2. Markou N., Kanakaki M., Myrianthefs P., Hadjiyanakos D., Vlassopoulos D., Damianos A., et al. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 184 (2006) 43-49
3. Faulx M.D., Storfer-Isser A., Kirchner H.L., Jenny N.S., Tracy R.P., and Redline S. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 30 (2007) 923-929
4. Canales M.T., Taylor B.C., Ishani A., Mehra R., Steffes M., Stone K.L., et al., and the Osteoporotic Fractures in Men (MrOS) Study Group. Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Med 9 3 (2008) 637-645
5. Launois S.H., Pépin J.L., and Lévy P. Sleep apnea in the elderly: a specific entity?. Sleep Med Rev 11 (2007) 87-97
6. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 1 (2003) 1-12
7. Rule A.D. Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease. Curr Opin Nephrol Hypertens 16 (2007) 242-249
8. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
9. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
10. Madero M., Sarnak M.J., and Stevens L.A. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 15 (2006) 610-616
11. Shlipak M.G., Praught M.L., and Sarnak M.J. Update on cystatin C: new insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens 15 (2006) 270-275
12. Macdonald J., Marcora S., Jibani M., Roberts G., Kumwenda M., Glover R., et al. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 48 (2006) 712-719
13. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
14. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
15. Bengtsson E., To F., Håkansson K., Grubb A., Brånén L., Nilsson J., et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25 10 (2005) 2151-2156
16. Bokarewa M., Abrahamson M., Levshin N., Egesten A., Grubb A., Dahlberg L., et al. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol 34 (2007) 1293-1301
17. Curhan G. Cystatin C a marker of renal function or something more?. Clin Chem 51 (2005) 293-294
18. Luc G., Bard J.M., Lesueur C., Arveiler D., Evans A., Amouyel P., et al. Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis 185 (2006) 375-380
19. Keller C.R., Odden M.C., Fried L.F., Newman A.B., Angleman S., Green C.A., et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 71 (2007) 239-244
20. Rule A.D., Larson T.S., Bergstralh E.J., Slezak J.M., Jacobsen S.J., and Cosio F.G. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 12 (2004) 929-937
21. Beauvieux M.C., Le Moigne F., Lasseur C., Raffaitin C., Perlemoine C., Barthe N., et al. New predictive equations improve monitoring of kidney function in patients with diabetes. Diabetes Care 30 8 (2007) 1988-1994
22. Rigalleau V., Lasseur C., Raffaitin C., Perlemoine C., Barthe N., Chauveau P., et al. The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects. Nephrol Dial Transplant 22 (2007) 813-818
23. Cirillo M., Anastasio P., and De Santo N.G. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant 20 (2005) 1791-1798
24. Björk J, Bäck SE, Sterner G, Carlson J, Lindström V, Bakoush O, et al. Prediction of relative glomerular filtration rate in adults: New improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest. in press.